Vitamin D3 receptor (VDR) expression in HC-11 mammary cells: regulation by growth-modulatory agents, differentiation, and Ha-ras transformation - PubMed (original) (raw)
Vitamin D3 receptor (VDR) expression in HC-11 mammary cells: regulation by growth-modulatory agents, differentiation, and Ha-ras transformation
M T Escaleira et al. Breast Cancer Res Treat. 1999 Mar.
Abstract
HC-11 mammary epithelial cells which originate from midpregnant BALB/c mice are able to differentiate in culture after epidermal (EGF) or basic fibroblast (FGF) growth factor pretreatment followed by lactogenic hormone stimulation (Dexamethasone, Insulin, and Prolactin - DIP). In our study, HC-11 cells exhibited specific vitamin D3 receptors (VDR) determined by Northern analysis or flow cytometry and responded to 10 nM vitamin D3 treatment displaying strong growth inhibition, arrest in G0/G1 phase without evidence of apoptosis, and VDR mRNA reduction, although the percentage of cells expressing VDR protein remained unchanged. In an attempt to verify if there was a correlation between the growth state of the cells and VDR levels, we have examined the effects of growth modulators such as EGF/bFGF and confluency and transformation by Ha-ras. A down-regulation of VDR expression was observed after Ha-ras transformation of HC-11 cells which desensitized the cells to the growth inhibitory effects of vitamin D3. EGF or bFGF decreased VDR in parental cells and EGF antagonized the antiproliferative activity of vitamin D3. As well, transition from proliferating to confluent state significantly reduced VDR levels only in parental cells. DIP-induced HC-11 cell differentiation (monitored by beta-casein transcripts), although leading to cell cycle arrest, increased VDR mRNA content, which seems to be rather related to lactogenic hormone induction than to differentiation itself. In fact, DIP-stimulated HC-11 cells in the absence of EGF pretreatment, or DIP-treated HC-11ras cultures, also displayed up-regulated VDR level even in the absence of differentiation. Concluding, mammary VDR levels might be regulated by growth modulating agents, by physiological conditions of the gland, and by the ras-mediated malignant transformation.
Similar articles
- Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.
De Santis ML, Kannan S, Smith GH, Seno M, Bianco C, Kim N, Martinez-Lacaci I, Wallace-Jones B, Salomon DS. De Santis ML, et al. Cell Growth Differ. 1997 Dec;8(12):1257-66. Cell Growth Differ. 1997. PMID: 9419414 - Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.
Hynes NE, Taverna D, Harwerth IM, Ciardiello F, Salomon DS, Yamamoto T, Groner B. Hynes NE, et al. Mol Cell Biol. 1990 Aug;10(8):4027-34. doi: 10.1128/mcb.10.8.4027-4034.1990. Mol Cell Biol. 1990. PMID: 2196443 Free PMC article. - Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE. Marte BM, et al. Mol Endocrinol. 1995 Jan;9(1):14-23. doi: 10.1210/mend.9.1.7760847. Mol Endocrinol. 1995. PMID: 7760847 - Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE, Hutchinson PE. Osborne JE, et al. Br J Dermatol. 2002 Aug;147(2):197-213. doi: 10.1046/j.1365-2133.2002.04960.x. Br J Dermatol. 2002. PMID: 12174089 Review. - Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
Perez-Fernandez R, Seoane S, Garcia-Caballero T, Segura C, Macia M. Perez-Fernandez R, et al. Curr Med Chem. 2007;14(29):3051-8. doi: 10.2174/092986707782793943. Curr Med Chem. 2007. PMID: 18220741 Review.
Cited by
- Vitamin D and differentiation in cancer.
Gocek E, Studzinski GP. Gocek E, et al. Crit Rev Clin Lab Sci. 2009;46(4):190-209. doi: 10.1080/10408360902982128. Crit Rev Clin Lab Sci. 2009. PMID: 19650715 Free PMC article. Review. - Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.
Byrne B, Welsh J. Byrne B, et al. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):703-7. doi: 10.1016/j.jsbmb.2006.12.061. Epub 2007 Jan 24. J Steroid Biochem Mol Biol. 2007. PMID: 17254776 Free PMC article. - Cellular and molecular effects of vitamin D on carcinogenesis.
Welsh J. Welsh J. Arch Biochem Biophys. 2012 Jul 1;523(1):107-14. doi: 10.1016/j.abb.2011.10.019. Epub 2011 Nov 9. Arch Biochem Biophys. 2012. PMID: 22085499 Free PMC article. Review. - Molecular actions of vitamin D contributing to cancer prevention.
Fleet JC. Fleet JC. Mol Aspects Med. 2008 Dec;29(6):388-96. doi: 10.1016/j.mam.2008.07.003. Epub 2008 Aug 8. Mol Aspects Med. 2008. PMID: 18755215 Free PMC article. Review. - Emerging perspectives: unraveling the anticancer potential of vitamin D3.
Wakle KS, Mokale SN, Sakle NS. Wakle KS, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2877-2933. doi: 10.1007/s00210-023-02819-5. Epub 2023 Nov 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37994947 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials